Send the following on WhatsApp
Continue to ChatDecreasing risk of hepatocellular carcinoma (HCC) development after the first 5 years of entecavir (ETV) or tenofovir (TDF) therapy in Caucasian chronic hepatitis B (CHB) patients - https://avesis.ankara.edu.tr/yayin/8a1dd97d-5127-4e44-9945-8a7c7ae30405/decreasing-risk-of-hepatocellular-carcinoma-hcc-development-after-the-first-5-years-of-entecavir-etv-or-tenofovir-tdf-therapy-in-caucasian-chronic-hepatitis-b-chb-patients